Biological targeted therapy for type 2 inflammation bronchial asthma
Bronchial asthma is a chronic inflammatory disease of the airway involving multiple inflammatory cells and cytokines. Severe asthma is characterized by recurrent attacks and persistent symptoms such as coughing, chest tightness, shortness of breath, and wheezing, etc., which are difficult to be alle...
Saved in:
| Main Author: | ZHANG Mingqiang, MU Xiangdong |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of New Medicine
2024-11-01
|
| Series: | Xin yixue |
| Subjects: | |
| Online Access: | https://www.xinyixue.cn/fileup/0253-9802/PDF/1735545799799-688098850.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Airway inflammation, bronchial hyperresponsiveness, and anti-asthma therapy responses in cough variant asthma and classic asthma with FEV1% ≥80% predicted
by: Xue Zhang, et al.
Published: (2025-04-01) -
Airway hyperresponsiveness in bronchial asthma: pathogenesis basics
by: I. A. Deyev, et al.
Published: (2002-12-01) -
Genetically Engineered Biologic Drugs in Management of Children with Bronchial Asthma
by: Svetlana V. Zaytseva, et al.
Published: (2021-12-01) -
Inflammation in Asthma: Mechanistic Insights and the Role of Biologics in Therapeutic Frontiers
by: Mohammad Irshad Reza, et al.
Published: (2025-05-01) -
Clinical Significance of Melatonin in Bronchial Asthma
by: А. V. Budnevskiy, et al.
Published: (2022-02-01)